The Saudi Food and Drug Authority (SFDA) has granted conditional approval for Anktiva, a groundbreaking cancer therapy, for ...

Saudi Arabia's Food and Drug Authority grants conditional approval for Anktiva, a new cancer therapy for advanced lung and ...

Men with newly diagnosed multiple myeloma are twice as likely as women to have stage III disease, with more kidney damage and ...

Even with breakthroughs, treatment for advanced squamous cell carcinoma is more complex. Patients often need more than one treatment. Many patients with this advanced cancer are cared for by a team of ...

Treatment for stage 3 myeloma is typically divided into phases. The goal is to achieve a deep remission, meaning the cancer ...

The activities of the “Advances in Nuclear Medicine: Precision Imaging and Therapy 2026” Conference were officially launched today, Saturday, in Abu Dhabi.The conference is organised by Burjeel Cancer ...

Many of these advances are the result of decades of work and clinical trials. Since the mid-1990s, the American Cancer ...

Inhibrx Biosciences, Inc. stays a Strong Buy with Q2 2026 ozekibart BLA catalyst, 2026 PFS data, and Ewing sarcoma updates.

Prostate cancer patients with metastatic disease and low-volume primary tumors appear to have a poor prognosis, according to ...

A record 70% of cancer patients are living five years past their diagnosis, according to a report released Tuesday by the ...

Misusing the words cancer and tumour can be confusing and misleading. This may be because the word "cancer" carries a stigma ...

Rates of multiple myeloma (MM), the second most common blood cancer in the United States, are increasing and are twice as ...